Your browser doesn't support javascript.
loading
Exploring the significance of lipids in Alzheimer's disease and the potential of extracellular vesicles.
Su, Huaqi; Masters, Colin L; Bush, Ashley I; Barnham, Kevin J; Reid, Gavin E; Vella, Laura J.
  • Su H; The Florey, The University of Melbourne, Parkville, Victoria, Australia.
  • Masters CL; School of Chemistry, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
  • Bush AI; The Florey, The University of Melbourne, Parkville, Victoria, Australia.
  • Barnham KJ; The Florey, The University of Melbourne, Parkville, Victoria, Australia.
  • Reid GE; The Florey, The University of Melbourne, Parkville, Victoria, Australia.
  • Vella LJ; School of Chemistry, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
Proteomics ; : e2300063, 2023 Aug 31.
Article en En | MEDLINE | ID: mdl-37654087
ABSTRACT
Lipids play a significant role in maintaining central nervous system (CNS) structure and function, and the dysregulation of lipid metabolism is known to occur in many neurological disorders, including Alzheimer's disease. Here we review what is currently known about lipid dyshomeostasis in Alzheimer's disease. We propose that small extracellular vesicle (sEV) lipids may provide insight into the pathophysiology and progression of Alzheimer's disease. This stems from the recognition that sEV likely contributes to disease pathogenesis, but also an understanding that sEV can serve as a source of potential biomarkers. While the protein and RNA content of sEV in the CNS diseases have been studied extensively, our understanding of the lipidome of sEV in the CNS is still in its infancy.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2023 Tipo del documento: Article